![](/img/cover-not-exists.png)
3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC)
Cho, B.C., Dy, G.K., Govindan, R., Kim, D.W., Pennell, N.A., Zalcman, G., Besse, B., Nogai, H., Rajagopalan, P., Ocker, M., Barlesi, F.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31741-5
Date:
September, 2015
File:
PDF, 63 KB
english, 2015